1. Up front

   Up front 29 January 2018 Pages: 507 - 508

   

2. Hope vs hype: where are we in type 1 diabetes?

   • Jay S. Skyler

   Review 23 December 2017 Pages: 509 - 516

   

3. Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach

   • Giuseppe Mancia
   • Guido Grassi

   Review 25 January 2018 Pages: 517 - 525

   

4. Considerations and guidelines for mouse metabolic phenotyping in diabetes research

   • Thierry Alquier
   • Vincent Poitout

   Review 16 November 2017 Pages: 526 - 538

   

5. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial

   • Per Oskarsson
   • Ramiro Antuna
   • Jan Bolinder

   Article Open access 23 December 2017 Pages: 539 - 550

   

6. Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial

   • Michael Gejl
   • Albert Gjedde
   • Jørgen Rungby

   Article Open access 29 November 2017 Pages: 551 - 561

   

7. Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study

   • Chieh-Hsiang Lu
   • Chen-Yi Yang
   • Huang-Tz Ou

   Article 14 November 2017 Pages: 562 - 573

   

8. Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes

   • Yun Huang
   • Xin Chen
   • Ji Hu

   Article 22 November 2017 Pages: 574 - 580

   

9. Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial

   • Jelena P. Seferovic
   • Marc A. Pfeffer
   • Nish Chaturvedi

   Article 03 November 2017 Pages: 581 - 588

   

10. Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort

    • Roy Taylor
    • Wilma S. Leslie
    • Michael E. J. Lean

    Article Open access 30 November 2017 Pages: 589 - 598

    

11. Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register

    • Andri O. Steinarsson
    • Araz Rawshani
    • Naveed Sattar

    Article Open access 09 January 2018 Pages: 599 - 606

    

12. Rates of glycaemic deterioration in a real-world population with type 2 diabetes

    • Louise A. Donnelly
    • Kaixin Zhou
    • Ewan R. Pearson

    Article Open access 19 December 2017 Pages: 607 - 615

    

13. Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998–2012

    • Raphael R. Goldacre

    Article Open access 11 November 2017 Pages: 616 - 625

    

14. Risk of lower limb amputation in a national prevalent cohort of patients with diabetes

    • Jason K. Gurney
    • James Stanley
    • Diana Sarfati

    Article 03 November 2017 Pages: 626 - 635

15. IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells

    • Alexandra Coomans de Brachène
    • Reinaldo S. Dos Santos
    • Decio L. Eizirik

    Short Communication 05 January 2018 Pages: 636 - 640

    

16. Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes

    • Michele Solimena
    • Anke M. Schulte
    • Piero Marchetti

    Article Open access 28 November 2017 Pages: 641 - 657

    

17. Combinatorial detection of autoreactive CD8⁺ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop

    • Eddie A. James
    • Joana R. F. Abreu
    • on behalf of the Immunology of Diabetes Society T Cell Workshop Committee

    Article 01 December 2017 Pages: 658 - 670

    

18. Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

    • Nicolai J. Wewer Albrechtsen
    • Kristine Færch
    • Jens J. Holst

    Article 05 January 2018 Pages: 671 - 680

    

19. Adapting to insulin resistance in obesity: role of insulin secretion and clearance

    • Sang-Hee Jung
    • Chan-Hee Jung
    • Sun H. Kim

    Article 01 December 2017 Pages: 681 - 687

    

20. Skeletal muscle insulin resistance is induced by 4-hydroxy-2-hexenal, a by-product of n-3 fatty acid peroxidation

    • Christophe O. Soulage
    • Laura Sardón Puig
    • Nicolas J. Pillon

    Article Open access 03 January 2018 Pages: 688 - 699

    

21. Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes

    • Joana F. Sacramento
    • Daniel J. Chew
    • Silvia V. Conde

    Article Open access 14 January 2018 Pages: 700 - 710

    

22. Development and characterisation of a novel glucagon like peptide-1 receptor antibody

    • Emma K. Biggs
    • Lihuan Liang
    • Fiona M. Gribble

    Article Open access 09 November 2017 Pages: 711 - 721

    

23. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na⁺/H⁺ exchanger, lowering of cytosolic Na⁺ and vasodilation

    • Laween Uthman
    • Antonius Baartscheer
    • Coert J. Zuurbier

    Short Communication Open access 02 December 2017 Pages: 722 - 726

    

24. Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice

    • Fengmin Li
    • Jian Yang
    • Xiaoyan Wang

    Article 28 October 2017 Pages: 727 - 737